【文獻(xiàn)標(biāo)題】Serum proteomic predicts effectiveness and reveals potential biomarkers for complications in liver transplant patients
【作者】Wenjing Wang, Bo Wang, Chang Liu et.al
【作者單位】西安交通大學(xué) （ Xi’an Jiaotong University）
【文獻(xiàn)中引用產(chǎn)品】
人ATP-檸檬酸裂解酶(ACLY)ELISA試劑盒
人纖維蛋白原α鏈(FGA)ELISA試劑盒
人載脂蛋白A1(ApoA1)ELISA試劑盒
【關(guān)鍵詞】 proteomic, serum biomarker, acute rejection (AR), ischemic-type biliary lesion (ITBL), liver transplantation
【DOI】https://doi.org/10.18632/aging.103381
【影響因子(IF)】4.6
【出版期刊】《AGING》
【產(chǎn)品原文引用】
All serum samples were analyzed blindly in triplicate and the concentrations of ACLY (Shanghai Hengyuan, H-12925), FGA (Shanghai Hengyuan Biotech, H-12843) and APOA1 (Shanghai Hengyuan, H-11508) were measured according to the manufacturer’s instructions respectively.
完整版PDF文獻(xiàn)請(qǐng)咨詢?cè)诰�客服或者電話聯(lián)系我司業(yè)務(wù)員！
更多公司福利請(qǐng)關(guān)注“恒遠(yuǎn)生物”微信公眾號(hào)！
或訪問(wèn)恒遠(yuǎn)生物官網(wǎng)（http://www.hnybio.com）
